undamentalytics Newsletter

Core Laboratories Inc. income statement

In fiscal 2025, Core Laboratories Inc. reported revenue of $527m, up 0.5% on the year before, operating income of $56.5m (a 10.7% margin) and net income of $29.7m, or $0.63 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Core Laboratories Inc.: income statement, annual
Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue470490510524527517
Cost of revenue—394400421418418
Gross profit—9611010310999
General and administrative—3840404548
Operating income454255595639
Interest expense91213121111
Income before tax363041464628
Income tax16104141612
Net income201937313016
Diluted EPS$0.42$0.42$0.77$0.66$0.63$0.33
Diluted shares (average)47m47m48m48m47m47m
EBITDA645970747154

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CLB vs RNGRBOOM vs CLBCLB vs KLXE

More: Oil & Gas Equipment & Services stocks compared, Energy sector, rankings of US companies

Figures from Core Laboratories Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Core Laboratories Inc.